The ultrasonographic diagnosis of polycystic ovary syndrome

References

• Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.
   Google Scholar
• Vara P, Niemineva K. Small cystic degeneration of ovaries as incidental finding in gynecological laparotomies. Acta Obstet Gynecol Scand 1951;31:94–99.
   PubMedGoogle Scholar
• Sommers SC, Wadman PJ. Pathogenesis of polycystic ovaries. Am J Obstet Gynecol 1956;29:181–187.
   Google Scholar
• Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83(9):3078–3082.
   PubMed Web of Science ®Google Scholar
• Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:335–359.
   Google Scholar
• Hull MGR. Epidemiology of infertility and polycystic ovarian desease: endocrinological and demographic studies. Gynecol Endocrinol 1987;1:235–245.
   PubMedGoogle Scholar
• Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992;41(10):1257–1266.
   PubMed Web of Science ®Google Scholar
• Homburg R. Polycystic ovary syndrome- from gynaecological curiosity to multisystemic endocrinopathy. Hum Reprod 1996;11:29–39.
   PubMed Web of Science ®Google Scholar
• Porewtsky L, Piper B. Insulin resistence, hypersecretion of LH, a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994;84:613–21.
   PubMedGoogle Scholar
• Genazzani AD, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 2004;81(1):114–119.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Regnani G, Mancini F, Iughetti L, Flamigni C, Venturoli S. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod 2002;17:771–776.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insulin receptor serin phosphorilation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96(2):801–810.
   Google Scholar
• Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S, Williamson R. Linkage and associationof insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349(9057):986–990.
   PubMedGoogle Scholar
• Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotrophin-releasing hormone agonist challenge in func- tional ovarian hyperandrogenism. J Clin Endocrinol Metab 1994;79(6):1686–1692.
   PubMedGoogle Scholar
• Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3(10):1873- 1876.
   Google Scholar
• Furui K, Suganuma N, Tsukahara S, Asada Y, Kikkawa F, Tanaka M, Ozawa T, Tomoda Y. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anom- alous LH variants. J Clin Endocrinol Metab 1994;78(1): 07–113.
   Google Scholar
• Okuda K, Yamada T, Imoto H, Komatsubara H, Sugimoto O. Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino- acid substitutions. Biochem Biophys Res Commun 1994; 200(1):584–590.
   PubMedGoogle Scholar
• Haavisto AM, Pettersson K, Bergendahl M, Virkamaki A, Huntaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1995;80(4):1257–1263.
   PubMedGoogle Scholar
• Dunaif A. Insuln resistance and tha polycystic ovary syn- drome: machanism and implications for pathogenesis. Endocr Rev 1997;18:774–800.
   PubMed Web of Science ®Google Scholar
• Homburg R. What is polycystic ovarian syndrome. A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod 2002;17:2495–2499.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19–25.
   Web of Science ®Google Scholar
• Goldzieher JW, Axelrod LR. Clinical and Biochemical features of polycystic ovarian desease. Fertil Steril 1963;14:631–653.
   PubMed Web of Science ®Google Scholar
• Kratochwill A, Urban GU, Friedrich F. Ultrasonic tomogra- phy of the ovaries. Ann Chir Gynecol 1972;61:211–214.
   Google Scholar
• Swanson M, Sauerbrei EE, Cooperberg PL. Medical implica- tions of ultrasonically detected polycystic ovaries. J Clin Ultrasound 1981;9(5):219–222.
   PubMedGoogle Scholar
• Adams J, Franks S, Polson DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gnadotropin releasing hormone. Lancet 1985;ii:1375-1378.
   Google Scholar
• Matsunaga I, Hata T, Kitao M. Ultrasonographic identifica- tion of polycystic ovary. Asia-Oceania J Obstet Gynecol 1985;11:227–232.
   PubMedGoogle Scholar
• Yee B, Barnes RB, Vargyas JM, Marrs RP. Correlation of transabdominal and transvaginal ultrasound measurements of follicle size and number with laparoscopic findings for in vitro fertilization. Fertil Steril 1987;47:828–832.
   PubMedGoogle Scholar
• Hull MGR. Polycystic ovarian desease: clinical aspects and prevalence. Res Clin Forums 1989;11:21–34.
   Google Scholar
• Goldstein SR. Incorporating endovaginal ultrasonography into the overall gynecologic examination. Am J Obstet Gynecol 1990;162:625–632.
   PubMedGoogle Scholar
• Battaglia C, Artini PG, D’Ambrogio G, Galli PA, Genazzani AR. Uterine and ovarian blood flow measurement. Does the full bladder modify the flow resistence? Acta Obstet Gynecol Scand 1994;73:716–718.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Oaki T, Okada M, Uchida A, Kitao M. Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome. Hum Reprod 1994;9:2255–2258.
   PubMedGoogle Scholar
• Battaglia C, Genazzani AD, Salvatori M, Giulini S, Artini PG, Genazzani AR, Volpe A. Doppler, ultrasonographic and endocrinological environment with regard to the number of small subcapsular follicles in polycystic ovary syndrome. Gynecol Endocrinol 1999;13:123–129.
   PubMed Web of Science ®Google Scholar
• Yeh HC, Futterweit W, Thornton JC. Polycystic ovarian desease: US features in 104 patients. Radiology 1987;163:111–116.
   PubMedGoogle Scholar
• Fox R, Corrigan E, Thomas PA, Hull MGR. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: pre- dictive power of endocrine tests. Clin Endocrinol 1991;34:127–131.
   PubMed Web of Science ®Google Scholar
• Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18(3): 598–603.
   PubMedGoogle Scholar
• Matsunaga I, Hata T, Kitao M. Ultrasonographic identifica- tion of polycystic ovary. Asia-Oceania J Obstet Gynecol 1985;11:227–232.
   PubMedGoogle Scholar
• Takahashi K, Eda Y, Abu-Musa A, Okada S, Yoshino K, Kitao M. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome. Hum Reprod 1994;9(7):1231–1236.
   PubMedGoogle Scholar
• Buckett, WM, Bouzayen R, Watkin KL, Tulandi T, Tan SL. Ovarian stromal echogenicity in women with normal and polycystic ovaries. Hum Reprod 1999;14:618–621.
   PubMedGoogle Scholar
• Robert Y, Dubrulle F, Gaillandre L, Ardaens Y, Thomas- Desrousseaux P, Lemaitre L, Dewailly D. Ultrasound assess- ment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil. Steril 1995;64:307–312.
   PubMedGoogle Scholar
• Nardo LG, Buckett WM, Khullar V. Determination of the best-fitting ultrasound formulaic method for ovarian volume measurement in women with polycystic ovary syndrome. Fertil Steril 2003;79(3):632–633.
   PubMedGoogle Scholar
• Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary sindrome: the ovarian stroma/total area ratio. Fertil Steril 2001;76:326–331.
   PubMed Web of Science ®Google Scholar
• Nicolini U, Ferrazzi E, Bellotti M, Travaglino P, Elli R, Scaperrotta RC. The contribution of sonographic evaluation of ovarian size in patients with polycystic ovarian disease. J Ultrasound Med 1985;4:341–351.
   Google Scholar
• Battaglia C, Regnani G, Petraglia F, Primavera MR, Salvatori M, Volpe A. Polycystic ovary sindrome: it is always bilateral? Ultrasound Obstet Gynecol 1999;14:183–187.
   PubMedGoogle Scholar
• Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population. Clin Endocrinol 1992;37:127–134.
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 1992;327:157–162.
   PubMed Web of Science ®Google Scholar
• Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and asociated and biochemical features in young women. Clin Endocrinol 1999;51:779–786.
   PubMed Web of Science ®Google Scholar
• Carmina E, Wong L, Chang L, et al. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod 1997;12:905–909.
   PubMed Web of Science ®Google Scholar
• Eden JA, Place GD, Carter GD, Alaghband-Zadeh, Pawson M. Is the polycystic ovary a cause of infertility in the ovulatory woman. Clin Endocrinol 1989;30:77–82.
   PubMed Web of Science ®Google Scholar
• Kurjak A, Zalud I, Jurkovic D, Alfirovic Z, Miljan M. Transvaginal color flow Doppler for the assessment of pelvic circulation. Acta Obstet Gynecol 1989;68:131–135.
   PubMed Web of Science ®Google Scholar
• Kurjak A, Jurkovic D, Alfirovic Z, Zalud I. Transvaginal color Doppler. J Clin Ultrasound 1990;18:227–234.
   PubMedGoogle Scholar
• Kurjak A, Kupesic-Urek S, Schulman H, Zalad I. Transva- ginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril 1991;56:870–873.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Larocca E, Lanzani A, Valentini M, Genazzani, A.R. Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. Gynecol Endocrinol 1990;4:245–250.
   PubMed Web of Science ®Google Scholar
• Sladkevicius P, Valentin L, Marsa`l K. Blood flow velocity in the uterine and ovarian arteries during the normal menstral cycle. Ultrasound Obstet Gynecol 1993;3:199–208.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Artini PG, D’Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995;172:108–113.
   PubMed Web of Science ®Google Scholar
• Brannstrom M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993;8:1762–1775.
   PubMed Web of Science ®Google Scholar
• Ajossa S, Guerriero S, Paoletti AM, Orru’ M, Melis GB. The antiandrogenic effect of flutamide improves uterine pefusion in women with polycystic ovary sindrome. Fertil Steril 2002;77:1136–1140.
   Google Scholar
• Zaidi J, Campbell S, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries-a possible new marker for diagnosis? Hum Reprod 1995;10:1992–1995.
   PubMed Web of Science ®Google Scholar
• Aleem FA, Predanic M. Transvaginal color Doppler determi- nation of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril 1996;65:510–516.
   PubMed Web of Science ®Google Scholar
• Ajossa S, Guerriero S, Paoletti AM, Orru M, Floris S, Mannias M, Melis GB. Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome. J Ass Reprod Genet 2001;18:436–440.
   PubMedGoogle Scholar
• Pan HA, Wu MH, Cheng YC, Li CH, Chang FM. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. Hum Reprod 2002;17:2011–2016.
   Google Scholar
• Battaglia C, Artini PG, Salvatori M, Giulini S, Petraglia F, Maxia N, Volpe A. Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations. Ultrasound Obstet Gynecol 1998;11:332–336.
   PubMed Web of Science ®Google Scholar
• Battaglia C, Artini PG, Genazzani AD, Gremigni R, Salvatori M, Sgherzi MR, Giulini S, Lombardo M, Volpe A. Color Doppler analysis in oligo- and amenorrheic women with polycystic ovary syndrome. Gynecol Endocrinol 1997;11:105–110.
   PubMed Web of Science ®Google Scholar
• Genazzzani AD, Petraglia F, Battaglia C, Gamba O, Volpe A, Genazzani AR. A long-term treatment with gonadotropin- releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulation function in patients with polycystic ovary sindrome. Fertil Steril 1997;67:463–468.
   PubMedGoogle Scholar
• Battaglia C, Genazzani AD, Artini PG, Salvatori M, Giulini S, Volpe A. Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary sindrome.Ultrasound Obstet Gynecol 1998;12:180–187.
   Google Scholar
• Battaglia C, Artini, PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S, Volpe A. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 1996;7:342–346.
   PubMed Web of Science ®Google Scholar
• Wild RA, Van Nort JJ, Grubb B, Bachman W, Hartz A, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 1990;54:255–259.
   PubMed Web of Science ®Google Scholar